Multilevel defects in the hematopoietic niche in essential thrombocythemia.
The role of the bone marrow niche in essential thrombocythemia remains unclear. Here, we observed multilevel defects in the hematopoietic niche of patients with JAK2V617F-positive essential thrombocythemia, including functional deficiency in mesenchymal stromal cells, immune imbalance, and sympathetic-nerve damage. Mesenchymal stromal cells from patients with JAK2V617F-positive essential thrombocythemia had a transformed transcriptome. In parallel, they showed enhanced proliferation, decreased apoptosis and senescence, attenuated ability to differentiate into adipocytes and osteoblasts, and insufficient support for normal hematopoiesis. Additionally, they were inefficient in suppressing immune responses. For instance, they poorly inhibited proliferation and activation of CD4-positive T cells and the secretion of the inflammatory factor soluble CD40-ligand. They also poorly induced formation of mostly immunosuppressive T helper 2 cells and the secretion of the anti-inflammatory factor interleukin-4. Furthermore, we identified WDR4 as a potent protein which was low expressed and correlated with increased proliferation, reduced senescence and differentiation, and insufficient support for normal hematopoiesis in mesenchymal stromal cells from patients with JAK2V617F-positive essential thrombocythemia. We also observed that loss of WDR4 in mesenchymal stromal cells downregulated the interleukin-6 level through the ERK-GSK3beta-CREB signaling based on our in vitro studies. Altogether, our results show that multilevel changes occur in the bone marrow niche of patients with JAK2V617F-positive essential thrombocythemia, and low expression of WDR4 in mesenchymal stromal cells may be critical for inducing hematopoietic related changes.